| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 02/07/2013 | US20130035331 Thiazole and oxazole kinase inhibitors |
| 02/07/2013 | US20130035329 Therapeutically active compositions and their methods of use |
| 02/07/2013 | US20130035327 Modulators of ATP-Binding Cassette Transporters |
| 02/07/2013 | US20130035326 Biaryl compounds and methods of use thereof |
| 02/07/2013 | US20130035324 Heterocyclic compounds and uses thereof |
| 02/07/2013 | US20130035323 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 02/07/2013 | US20130034520 Hepatitis C Virus Inhibitors |
| 02/07/2013 | US20130032787 Heterocyclic compound and organic light-emitting device including the same |
| 02/07/2013 | CA2843836A1 Uracil derivative and use thereof for medical purposes |
| 02/07/2013 | CA2843805A1 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament |
| 02/07/2013 | CA2843238A1 N-hetero-ring-substituted amide derivative |
| 02/07/2013 | CA2842364A1 Nuclear transport modulators and uses thereof |
| 02/06/2013 | EP2552915A1 Compounds and method for treatment of hiv |
| 02/06/2013 | EP2552909A1 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists |
| 02/06/2013 | EP2552905A1 B-raf kinase inhibitors |
| 02/06/2013 | EP2552214A1 Pyrazolyl-pyrimidines as kinase inhibitors |
| 02/06/2013 | EP2552209A1 Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use |
| 02/06/2013 | EP2552208A1 Imidazolyl-imidazoles as kinase inhibitors |
| 02/06/2013 | CN1938298B Methods for minimizing thioamide impurities |
| 02/06/2013 | CN102918031A Radiolabeled compounds and methods thereof |
| 02/06/2013 | CN102918027A Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| 02/06/2013 | CN102911168A Method for modifying spirooxazine compound into oxazole compound |
| 02/06/2013 | CN102911161A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 02/06/2013 | CN102911112A Heterocyclic compound and organic light-emitting device including the same |
| 02/06/2013 | CN102911110A N, N-disubstituted-N'-phthaloyl group-1, 3-diamine derivative and preparation method thereof |
| 02/06/2013 | CN101166736B Polymorph form II of tanaproget |
| 02/05/2013 | US8367836 Pyridinone antagonists of alpha-4 integrins |
| 02/05/2013 | US8367704 Process for preparation of 2-methyl-2′ phenylpropionic acid derivatives and novel intermediate compounds |
| 02/05/2013 | US8367679 Biaryl carboxamides |
| 02/05/2013 | US8367668 Pyridazinone derivatives |
| 02/05/2013 | US8367666 3-carbamoyl-2-pyridone derivatives |
| 02/05/2013 | US8367664 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors |
| 02/05/2013 | US8367663 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety |
| 02/05/2013 | CA2697495C Xinafoate salt of n4-[(2,2-difluoro-4h-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-n2-[3-(methylaminocarbonylmethyleneoxy)phenyl]-2,4-pyrimidinediamine |
| 02/05/2013 | CA2591033C Heterocyclic aspartyl protease inhibitors |
| 02/05/2013 | CA2539767C 1,3-benzoxazolyl derivatives as kinase inhibitors |
| 02/05/2013 | CA2521992C 1,2,4-oxadiazole benzoic acid compounds |
| 02/05/2013 | CA2520894C Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
| 02/05/2013 | CA2508792C Heterocyclic compounds, methods of making them and their use in therapy |
| 01/31/2013 | WO2013016720A2 Novel substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases |
| 01/31/2013 | WO2013016206A1 Anti-biofilm compounds |
| 01/31/2013 | WO2013015661A2 Novel prodrugs of 5-(2,4-dihydroxy-5-isopropylphenyl)-n-ethyl-4-(5-methyl1-1,2,4-oxadiazol-3-yl)isoxazole-3-carboxamide |
| 01/31/2013 | WO2013014170A1 Oxazole and thiazole derivatives as selective protein kinase inhibitors (c-kit) |
| 01/31/2013 | WO2013014165A1 Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators |
| 01/31/2013 | WO2013014104A1 Bis-indolic derivatives, their uses in particular as antibacterials |
| 01/31/2013 | WO2013014060A1 Substituted quinolines and their use as medicaments |
| 01/31/2013 | US20130030172 Methods of Preparing Quinoline Derivatives |
| 01/31/2013 | US20130030171 Pyrimidinyl Aryl Urea Derivatives being FGF Inhibitors |
| 01/31/2013 | US20130030022 Compounds Which Selectively Modulate The CB2 Receptor |
| 01/31/2013 | US20130030006 Agent for preventing or treating diseases accompanied by urinary pain |
| 01/31/2013 | US20130029995 Substituted Bicyclic Aromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands |
| 01/31/2013 | US20130029990 Pyrazole p38 map kinase inhibitors |
| 01/31/2013 | US20130029988 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 01/31/2013 | US20130029987 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith |
| 01/31/2013 | US20130029981 Compounds, compositions, and methods for controlling biofilms |
| 01/31/2013 | US20130029979 Fused bicyclic compound |
| 01/31/2013 | US20130029978 Novel aryl urea derivative |
| 01/31/2013 | US20130029975 Cgrp antagonists |
| 01/31/2013 | US20130029973 Tetrahydrobenzothiophene compound |
| 01/31/2013 | US20130029971 Cxcr3 receptor antagonists |
| 01/31/2013 | US20130029966 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof |
| 01/31/2013 | US20130029964 [5, 6] heterocyclic compound |
| 01/31/2013 | US20130029963 1,2,4-triazine-4-amine derivatives |
| 01/31/2013 | US20130029949 Substituted Quinolines and Their Use As Medicaments |
| 01/31/2013 | US20130029942 Compounds and therapeutical uses thereof |
| 01/31/2013 | US20130029845 Isoxazolines for controlling invertebrate pests |
| 01/31/2013 | US20130028989 Materials and method for inhibiting replication protein a and uses thereof |
| 01/31/2013 | US20130028966 Broad Spectrum Antiviral and Antiparasitic Agents |
| 01/31/2013 | US20130028879 Method for controlling particular insect pests by applying anthranilamide compounds |
| 01/31/2013 | US20130028843 Kallikrein 7 modulators |
| 01/31/2013 | US20130025618 Novel cationic 4-aminoindoles, dye composition comprising a cationic 4-aminoindole, processes therefor and uses thereof |
| 01/31/2013 | CA2843022A1 Substituted quinolines and their use as medicaments |
| 01/31/2013 | CA2842830A1 Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof,and use thereof as herbicides and plant growth regulators |
| 01/31/2013 | CA2842508A1 Bis-indolic derivatives, their uses in particular as antibacterials |
| 01/31/2013 | CA2840029A1 Oxazole and thiazole derivatives as selective protein kinase inhibitors (c-kit) |
| 01/30/2013 | EP2550268A1 Analogues for the treatment or prevention of flavivirus infections |
| 01/30/2013 | EP2550266A2 Heterocyclic compounds useful for kinase inhibition |
| 01/30/2013 | EP2550262A1 Analogues for the treatment or prevention of flavivirus infections |
| 01/30/2013 | EP2549875A1 Soluble guanylate cyclase activators |
| 01/30/2013 | CN102906083A Novel substituted triazole derivatives as gamma secretase modulators |
| 01/30/2013 | CN102906080A Compounds for the treatment of hepatitis C |
| 01/30/2013 | CN102898408A Benzopyran compounds, preparation method and applications thereof |
| 01/30/2013 | CN102898386A Quinazoline derivative, preparation method, intermediate, composition and application |
| 01/30/2013 | CN102898377A Novel phthalazinone derivatives and uses thereof |
| 01/30/2013 | CN101321525B Heteroaryl substituted piperidine derivatives as L-CPT1 inhibitors |
| 01/29/2013 | US8362264 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 01/29/2013 | US8362257 Nitrogen-containing heterocyclic compound and pest control agent |
| 01/29/2013 | US8362249 CXCR3 receptor antagonists |
| 01/29/2013 | US8362240 Taxol derivatives with antitumor activity |
| 01/29/2013 | US8362238 Method for refining of high purity of tacrolimus |
| 01/29/2013 | US8362020 Hepatitis C virus inhibitors |
| 01/29/2013 | US8362015 Aminoacyl prodrug derivatives and medicaments for treatment of thromboembolic disorders |
| 01/29/2013 | US8362014 ABT-263 crystalline forms |
| 01/29/2013 | US8362013 Salt of ABT-263 and solid-state forms thereof |
| 01/29/2013 | US8362012 Benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and a use thereof |
| 01/29/2013 | US8362008 Amido-thiophene compounds and their use as 11-beta-HSD1 inhibitors |
| 01/29/2013 | US8362004 Piperazine analogs as broad-spectrum influenza antivirals |
| 01/29/2013 | US8362003 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 01/29/2013 | US8362001 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 01/29/2013 | US8362000 Azetidinyl diamides as monoacylglycerol lipase inhibitors |